drugset / Trial / NCT00427219
The Safety and Efficacy of Ozarelix to Treat Men With Lower Urinary Tract Symptoms Due to Enlargement of the Prostate
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is to compare the efficacy and safety of ozarelix 15 mg given intramuscular (IM) 2 weeks apart on the improvement of symptoms and the duration of improvement for up to 6 months in men with Benign Prostatic Hypertrophy (BPH) who are over 50 years of age.
Timeline
- Start
- 2007-01-23
- Primary completion
- 2008-02-27
- Completion
- 2008-02-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ozarelix | Protein / enzyme biologic | 15 mg | Intramuscular |